Overcoming the winner's curse: Estimating penetrance parameters from case-control data

American Journal of Human Genetics

Volumn 80, Issue 4, 2007, Pages 605-615

  Zöllner, Sebastian ^a   Pritchard, Jonathan K ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC ALGORITHM; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; PENETRANCE; POPULATION GENETIC PARAMETERS; PREVALENCE; PRIORITY JOURNAL; SAMPLE SIZE; STATISTICAL ANALYSIS; UNCERTAINTY;

EID: 34147119077     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/512821     Document Type: Article

References (22)

1. S.Z.'s Web site, http://www.sph.umich.edu/csg/zollner (for supplementary material containing results for additional genetic models, the size of the 95% confidence region for different sample sizes, and results for misspecified disease prevalence)
2. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
3. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN (2003) Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33:177-182
4. Herbert A, Gerry NP, McQueen MB, Heid IM, Pfeufer A, Illig T, Wichmann HE, Meitinger T, Hunter D, Hu FB, et al (2006) A common genetic variant is associated with adult and childhood obesity. Science 312:279-283
5. Edwards AO, Ritter R, Abel JK, Manning A, Panhuysen C, Farrer LA (2005) Complement factor H polymorphism and age-related macular degeneration. Science 308:421-424
6. Capen EC, Clapp RV, Campbell WM (1971) Competitive bidding in high-risk situations. J Petrol Technol 23:641-653
7. Göring HHH, Terwilliger JD, Blangero J (2001) Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet 69:1357-1369
8. Allison DB, Fernandez JR, Heo M, Zhu S, Etzel C, Beasley TM, Amos CI (2002) Bias in estimates of quantitative-trait-locus effect in genome scans: demonstration of the phenomenon and a method-of-moments procedure for reducing bias. Am J Hum Genet 70:575-585
9. Siegmund D (2002) Upward bias in estimation of genetic effects. Am J Hum Genet 71:1183-1188
10. Sun L, Bull SB (2005) Reduction of selection bias in genomewide studies by resampling. Genet Epidemiol 28:352-367
11. Van Steen K, McQueen MB, Herbert A, Raby B, Lyon H, De-Meo DL, Murphy A, Su J, Datta S, Rosenow C, et al (2005) Genomic screening and replication using the same data set in family-based association testing. Nat Genet 37:683-691
12. Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516-1517
13. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J (1998) A Pro12-Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 20:284-287
14. Pritchard JK, Przeworski M (2001) Linkage disequilibrium in humans: models and data. Am J Hum Genet 69:1-14
15. Clement K, Hercberg S, Passinge B, Galan P, Varroud-Vial M, Shuldiner AR, Beamer BA, Charpentier G, Guy-Grand B, Froguel P, et al (2000) The Pro112Gln and Pro12Ala PPARγ mutations in obesity and type 2 diabetes. Int J Obes Relat Metab Disord 24:391-393
16. Hara K, Okada T, Tobe K, Yasuda K, Mori Y, Kadowaki H, Hagura R, Akanuma Y, Kimura S, Ito C, et al (2000) The Pro12Ala polymorphism in PPARγ2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271:212-216
17. Mancini FP, Vaccaro O, Sabatino L, Tufano A, Rivellese AA, Riccardi G, Colantuoni V (1999) Pro12Ala substitution in the peroxisome profilerator activated receptor-γ2 is not associated with type 2 diabetes. Diabetes 48:1466-1468
18. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P (2000) Impact of the peroxisome profilerator activated receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 24:195-199
19. Ringel J, Engli S, Distler A, Sharma AM (1999) Pro12Ala missense mutation of the peroxisome profilerator activated receptor and diabetes mellitus. Biochem Biophys Res Commun 254:450-453
20. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl CM, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C et al (2000) The common PPARγPro12Ala12 polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26:76-80
21. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047-1053
22. Voight B, Pritchard JK (2005) Confounding from cryptic relatedness in case-control association studies. PLoS Genet 1:e32